APA

Dryden M., Zhang Y., Wilson D., Iaconis J. P. & Gonzalez J. (20170814). A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities. : The Journal of antimicrobial chemotherapy.

Chicago

Dryden Matthew, Zhang Yingyuan, Wilson David, Iaconis Joseph P and Gonzalez Jesus. 20170814. A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities. : The Journal of antimicrobial chemotherapy.

Harvard

Dryden M., Zhang Y., Wilson D., Iaconis J. P. and Gonzalez J. (20170814). A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities. : The Journal of antimicrobial chemotherapy.

MLA

Dryden Matthew, Zhang Yingyuan, Wilson David, Iaconis Joseph P and Gonzalez Jesus. A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities. : The Journal of antimicrobial chemotherapy. 20170814.